A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Biliary Cholangitis With Inadequate Response or Intolerance to Ursodeoxycholic Acid
Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors
A study to assess long-term safety of tazemetostat in adult participants of all ages with any disease treated with tazemetostat in a previous clinical study
A study to assess the effectiveness and safety of 2 dosage regimens of oral fidrisertib (IPN60130) for the treatment of Fibrodysplasia Ossificans Progressiva (FOP)
A Study of Elafibranor in Adults with Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis.